The UK Bribery Bill was granted Royal Assent on 8 April and is now official law1,2. The legislation applies to all companies, including drug and medical device entities.
The Bribery Act 2010, among other things, creates a new offence of failure by a commercial organisation to prevent a bribe being paid for or on its behalf3...
